bromodeoxyuridine has been researched along with Neoplasms in 169 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 70 (41.42) | 18.7374 |
| 1990's | 41 (24.26) | 18.2507 |
| 2000's | 43 (25.44) | 29.6817 |
| 2010's | 12 (7.10) | 24.3611 |
| 2020's | 3 (1.78) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Hać, A; Herman-Antosiewicz, A; Rak, J; Spisz, P; Zdrowowicz, M | 1 |
| Çetin, İ; Topçul, MR | 1 |
| Anderson, B; Drinkwater, K; Hampel, D; Mody, A; Seangmany, N; Shim, M | 1 |
| Roth, J; Taatjes, DJ | 1 |
| Medin, JA; Neschadim, A | 1 |
| Adame, A; Brandstaetter, H; Desplats, P; Florio, J; Mante, M; Masliah, E; Meier, D; Rockenstein, E; Ubhi, K; Winter, S | 1 |
| Iimori, M; Kataoka, Y; Kiniwa, M; Kitao, H; Maehara, Y; Matsuoka, K; Morodomi, Y; Niimi, S; Oki, E; Saeki, H; Shigeno, K; Tokunaga, E | 1 |
| Balzarini, J; Brancale, A; Kandil, S; McGuigan, C; Rat, S; Westwell, AD | 1 |
| Ando, K; Hirayama, R; Kashino, G; Kinashi, Y; Koike, S; Liu, Y; Masunaga, S; Ono, K; Suzuki, M; Uzawa, A | 1 |
| Adachi, E; Fujisaki, H; Hattori, S; Irie, S; Sasaki, J | 1 |
| Affolter, T; Buckman, D; Christensen, JG; Cullinane, C; Fahey, NR; Kuszpit, K; Lappin, PB; Li, W; Lira, ME; Nichols, T; O'Brien, P; Painter, CL; Spilker, M; Wong, A; Yan, Z; Zasadny, K; Zhang, CC; Zhang, Q | 1 |
| Murasaki, T; Nakanishi, M; Ogawa, K; Shirai, T; Sugiura, S | 1 |
| Fowler, DH; Lavie, A; Medin, JA; Neschadim, A; Sato, T; Wang, JC | 1 |
| Blackman, BR; Blais, EM; Cowan, CR; Fox, JW; Grigera, PR; Jeffery, ED; Papin, JA; Parsons, JT; Sherman, NE; Tilghman, RW; Tschumperlin, DJ | 1 |
| Friedenson, B; Lech, D; Levin, B | 1 |
| Mai, L; Wei, Q; Yao, A; Zhang, D; Zhang, Z; Zhou, Q | 1 |
| Bengtsson, E; Ekholm-Reed, S; Erlandsson, F; Hellström, AC; Wählby, C; Zetterberg, A | 1 |
| Auwerx, J; Egler, V; Fajas, L; Lefebvre, AM; Miard, S; Reiter, R | 1 |
| Bollag, WB; Dickinson, D; Hsu, S; Lewis, J; Lockwood, P; Osaki, T; Schuster, G; Singh, B; Ueta, E; Wataha, J; Yamamoto, T | 1 |
| BECK, C; GRAHAM, OL; GROSS, A; KIT, S | 1 |
| BOND, SB; KRISS, JP; MARUYAMA, Y; REVESZ, L; TUNG, LA | 1 |
| PAINTER, RB; RASMUSSEN, RE | 1 |
| DELIHAS, N; EIDINOFF, ML; RICH, MA | 1 |
| KRISS, JP; REVESZ, L | 2 |
| Chen, CH; Lee, MH; Lozano, G; Wen, YY; Yang, HY | 1 |
| Harris, RC; Singh, AB | 1 |
| Chiao, JW; Chung, FL; Conaway, CC; Liu, D; Ramaswamy, G; Wang, L; Wu, H | 1 |
| Bhawe, KM; Blake, RA; Clary, DO; Flanagan, PM | 1 |
| Jiang, J; Kamendulis, LM; Kaster, J; Klaunig, JE; Lafferty, JS | 1 |
| Bronson, RT; Contreras, B; Ewen, ME; Loda, M; Takahashi, C | 1 |
| Joseph, J; Somasundaram, K; Wajapeyee, N | 1 |
| Agarwal, MK; Cucullo, L; Dini, G; Fazio, V; Garrity-Moses, M; Hallene, KL; Igboechi, C; Ilkanich, EV; Janigro, D; Kight, KM | 1 |
| Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S | 1 |
| Begg, AC; Bussink, J; Haustermans, KM; Janssen, HL; Ljungkvist, AS; Rijken, PF; Sprong, D; van der Kogel, AJ | 1 |
| Hori, H; Kinashi, Y; Masunaga, S; Nagasawa, H; Nagata, K; Ono, K; Suzuki, M; Uto, Y | 1 |
| Burns, A; Jove, R; Mora, LB; Sebti, S; Turkson, J; Zhang, S | 1 |
| Barbi, C; Bonafé, M; Franceschi, C; Gravina, S; Mondello, C; Monti, D; Rossi, M; Salvioli, S; Storci, G; Tiberi, L; Tocco, F; Trapassi, C | 1 |
| Harris, MC; Marshall, DJ; Mateo, LR; McCarthy, SG; McCauley, C; Rudnick, KA; Snyder, LA | 1 |
| Chauffert, B; Ghiringhelli, F; Kroemer, G; Martin, F; Parcellier, A; Puig, PE; Roux, S; Schmitt, E; Solary, E; Zitvogel, L | 1 |
| Garcia, AJ; Lawson, DA; Wang, S; Witte, ON; Wu, H; Wu, M | 1 |
| Kamendulis, LM; Klaunig, JE | 1 |
| Hai, T; Lu, D; Wolfgang, CD | 1 |
| Berlanda, G; Bongiorno, G; Carbone, R; Chierici, E; Fiorentini, F; Giorgetti, L; Marangi, I; Milani, P; Pelicci, PG; Piseri, P; Podestà, A; Zanardi, A | 1 |
| Andrini, LB; Barbeito, CG; Errecalde, AL; García, MN | 1 |
| Golub, TR; Jacks, T; Kumar, MS; Lu, J; Mercer, KL | 1 |
| Terry, NH; White, RA | 1 |
| Kawamoto, JK; Shimizu, N; Utani, K | 1 |
| Esteva, FJ; Hortobagyi, GN; Lan, KH; Lu, CH; Mills, GB; Neal, CL; Sun, MH; Tseng, LM; Wyszomierski, SL; Yu, D | 1 |
| Hosokawa, H; Ishibashi, J; Ishikawa, T; Kitamura, S; Nagayama, M; Sumida, K; Yamashita, K | 1 |
| Begum, S; Califano, J; Henrique, R; Hoque, MO; Jeronimo, C; Kim, MS; Lendvai, A; Liu, J; Ongenaert, M; Ostrow, KL; Park, HL; Poeta, ML; Rosenbaum, E; Schuuring, E; Sidransky, D; Van Criekinge, W; van der Zee, AG; Westra, W; Wisman, GB; Yamashita, K | 1 |
| Aiken, M; Glatstein, E; Hsu, SM; Kinsella, TJ; Mitchell, JB; Morstyn, G; Rowland, J; Russo, A | 1 |
| Galasso, GJ | 1 |
| Hirsch, MS; Wong, KK | 1 |
| White, DO | 1 |
| Collins, JM; Jenkins, J; Kinsella, TJ; Kornblith, P; Mitchell, JB; Myers, CE; Rowland, J; Russo, A; Schwade, J; Speyer, J | 1 |
| Glatstein, E; Kinsella, TJ; Mitchell, JB; Morstyn, G; Russo, A | 1 |
| Gratzner, H; Hsu, SM; Kinsella, T; Mitchell, J; Morstyn, G; Russo, A | 1 |
| De Clercq, E; Wildiers, J | 1 |
| Hirsch, MS | 1 |
| Furusawa, M; Jimi, S; Mashiba, H; Matsunaga, K; Nomura, Y; Yagawa, K; Yoshinaga, H | 1 |
| Jonasson, J; Santesson, B; Ström, A | 1 |
| Griffey, S; Metzger, L; Théon, AP | 1 |
| Herbergs, J; Hopman, AH; Ramaekers, FC; Speel, EJ | 1 |
| Fowler, JF; Gilchrist, KW; Kim, YJ; Kinsella, TJ; Morrissey, LW; Ritter, MA | 1 |
| De Bruijn, EA; De Clercq, E; Keizer, HJ; Tjaden, UR | 1 |
| Martin, H | 1 |
| Garin-Chesa, P; Lloveras, B; Melamed, M; Myc, A | 1 |
| Danova, M; Dionigi, P; Ferrari, C; Giordano, M; Mazzini, G; Riccardi, A | 1 |
| Inokuchi, T; Sano, K; Sekine, J; Uehara, M | 1 |
| Ceccarelli, C; Danova, M; Derenzini, M; Trerè, D | 1 |
| Dolbeare, F | 1 |
| Bertuzzi, A; Gandolfi, A; Iacoviello, D; Sinisgalli, C | 1 |
| Bosq, J; Bourhis, J | 1 |
| Bertuzzi, A; Gandolfi, A; Sinisgalli, C; Starace, G; Ubezio, P | 1 |
| Au, JL; Weaver, JR | 1 |
| Crompton, NE; Fodor, G; Hauser, B; Kaser-Hotz, B; Ruckstuhl, H; Schwyn, U | 1 |
| Duprez, A; Vignaud, JM | 1 |
| Antognoni, P; Danova, M; Luraghi, R; Richetti, A; Tordiglione, M | 1 |
| Choi, YH; Cowan, K; Craig, C; Katayose, D; Kim, M; Li, Z; Mudahar, B; Ohri, E; Seth, P; Srivastava, S; Wersto, R | 1 |
| Blattmann, H; Crompton, NE; Hauser, B; Kaser-Hotz, B; Klink, B; Parvis, A; Ruslander, D; Schwyn, U | 1 |
| Durand, RE; Raleigh, JA | 1 |
| Au, JL; Gan, Y; Weaver, JR | 1 |
| Coleman, CN; Mitchell, JB | 1 |
| Knühmann, K; Sack, H; Streffer, C; Stüben, G; Zölzer, F | 1 |
| de Jong, JM; Engelen, JJ; Kleinjans, JC; Schilderman, PA; Welle, IJ; Zwingmann, IH | 1 |
| Rew, DA; Wilson, GD | 1 |
| Bedner, E; Darzynkiewicz, Z; Deptala, A; Gorczyca, W; Li, X; Melamed, MR | 1 |
| Rew, DA | 1 |
| Flaman, JM; Foltz, G; Hieter, P; Irvin, DK; Jarell, AD; Kanning, K; Kinoshita, Y; Kornblum, HI; Morrison, RS; Nelson, PS; Schuster, J; Sopher, BL | 1 |
| Blattmann, H; Bläuenstein, P; Crompton, NE; Gardelle, O; Guenther, I; Kaser-Hotz, B; Leenders, KL; Roelcke, U; Ryser, JE; Schubiger, AP; Vontobel, P | 1 |
| Johnson, GM; Knudson, CM; Korsmeyer, SJ; Lin, Y | 1 |
| Hori, H; Kinashi, Y; Masunaga, SI; Murayama, C; Nagasawa, H; Nishimura, Y; Ono, K; Sadahiro, S; Suzuki, M; Takagaki, M; Tsuchiya, I; Uto, Y | 1 |
| Anisimov, VN; Butov, AA; Volkov, MA | 1 |
| Berry, SE; Kinsella, TJ | 1 |
| Kinashi, Y; Kobayashi, T; Masunaga, S; Ono, K; Sakurai, Y; Suzuki, M; Takagaki, M | 1 |
| Cardiff, RD; DeGregori, J; Field, SJ; Fujiwara, Y; Gore, L; Greenberg, M; Orkin, SH; Thompson, M; Yang, H; Zhu, JW | 1 |
| Masunaga, S; Ono, K | 1 |
| Doljanski, F; Katzav, S; Markson, Y; Weiss, DW | 1 |
| Madreiter, H; Osieka, R; Schmidt, CG | 1 |
| Parsons, PG; Smellie, SG | 1 |
| Manteuil-Brutlag, S | 1 |
| Phillips, TL | 1 |
| Dewald, G; Dicken, CH; Gordon, H | 1 |
| Kaplan, HS | 2 |
| Munzenrider, JE | 1 |
| Michalová, K; Musilová, J; Urban, J | 1 |
| Streffer, C | 1 |
| Kit, S | 1 |
| Kanno, M; Nakamura, S; Takeda, Y | 1 |
| Katayanagi, N; Muto, T; Suzuki, T; Tanaka, O | 1 |
| Wilson, GD | 2 |
| Bennett, MH | 1 |
| Bokhari, SA; Miller, MA; Qadir, K; Raza, A | 1 |
| Brooks, DJ; Garewal, HS | 1 |
| Hsu, TC | 1 |
| Inoue, S; Mizuno, S | 1 |
| Kubus, J; Linden, MD; Torres, FX; Zarbo, RJ | 1 |
| Brugnatelli, S; Danova, M; Giordano, M; Mazzini, G; Riccardi, A | 1 |
| Muraoka, R; Shimomatsuya, T; Tanigawa, N | 1 |
| Cancellieri, A; Ceccarelli, C; Derenzini, M; Eusebi, V; Farabegoli, F; Trerè, D | 1 |
| Berger, T; Crone, K; Gray, J; Lampkin, B; Mazewski, C; Miller, MA; Raza, A; Reising, J; Sawaya, R; Sheikh, Y | 1 |
| Bush, C; Parkins, CS; Price, P; Steel, GG | 1 |
| Hardonk, MJ; Harms, G | 1 |
| Nakamura, S | 1 |
| Camargo, M; Cervenka, J; Krawczun, MS | 1 |
| Falini, B; Gambacorta, M; Veronese, S | 1 |
| Clarke, PJ; Ffrench, M; Magaud, JP; Mason, DY; Rimokh, R; Sargent, I | 1 |
| Begg, AC; Bush, C; Imrie, PR; Ormerod, MG; Parkins, CS; Price, P; Steel, GG | 1 |
| McNally, NJ | 1 |
| Cook, JA; Glatstein, E; Mitchell, JB; Russo, A; Straus, KL | 1 |
| Cho, EK; Chung, CH; Lee, SS; Lee, TS; Park, JS | 1 |
| Coleman, CN | 1 |
| Murakami, T; Sasaki, K; Takahashi, M | 1 |
| Kikuyama, S | 1 |
| Iwasa, K; Kosaka, T; Miwa, K; Miyazaki, I; Ohyama, S; Yamaguti, A; Yonemura, Y | 1 |
| Bärwolff, D; Reefschläger, J; Wutke, K; Wutzler, P | 1 |
| Dolbeare, F; Gray, J; Waldman, FM | 1 |
| Barrows, GH; Hu, YQ | 1 |
| Ascari, E; Brugnatelli, S; Danova, M; Dörmer, P; Girino, M; Mazzini, G; McNally, NJ; Riccardi, A; Ucci, G; Wilson, G | 1 |
| Bennett, MH; Des Rochers, C; Dische, S; Lewis, AA; McNally, NJ; Saunders, MI; Wilson, GD | 1 |
| Rafla, S; Yang, SJ | 1 |
| Matsumura, K; Sasaki, K; Shinozaki, F; Takahashi, M; Tsuji, T | 1 |
| Beverstock, GC; Fibbe, WE; Hakvoort, HW; Kluin-Nelemans, JC; van Dierendonck, JH; van Rood, JJ; Willemze, R | 1 |
| Beisker, W; Dolbeare, F; Gray, JW; Pallavicini, MG; Waldman, F | 1 |
| Göhde, W; Mauro, F; Schumann, J; Spanò, M; Teodori, L | 1 |
| Denekamp, J | 1 |
| Ogino, T; Sasaki, K; Takahashi, M | 1 |
| Glatstein, E; Kinsella, TJ; Mitchell, JB; Russo, A | 1 |
| Candelaresi, GL; Coverlizza, S; Gaiola, O; Poccardi, G; Risio, M | 1 |
| Göhde, W; Mauro, F; Schumann, J; Teodori, L | 1 |
| deFazio, A; Tattersall, MH | 1 |
| Nakajima, T; Onoyama, Y; Tanaka, M | 1 |
| Benoit, Y; De Clercq, E; Delbeke, MJ; Laureys, G | 1 |
| Dunphy, E; Kärcher, H; McNally, NJ; Pfragner, R; Wilson, GD | 1 |
| Franke, HD | 1 |
| Balabanova, G; Becker, Y; Kotler, M; Weinberg, E | 1 |
| Lieber, MM; Sherr, CJ; Todaro, GJ | 1 |
| Black, PH; Hirsch, MS | 1 |
| Bagshaw, MA; Goffinet, DR | 1 |
| Anken, M; De Torres, RA; Dubbs, DR; Kit, S | 1 |
| Takahashi, M; Tanaka, N | 1 |
| Olenov, IuM | 1 |
| Hozumi, M | 1 |
| Suit, HD | 1 |
32 review(s) available for bromodeoxyuridine and Neoplasms
| Article | Year |
|---|---|
[CHEMICAL RADIOSENSITIZATION].
Topics: Antifibrinolytic Agents; Bromodeoxyuridine; Dactinomycin; DNA; DNA, Neoplasm; Ethylmaleimide; Hyperbaric Oxygenation; Naphthoquinones; Neoplasms; Retinoids; Vitamin K | 1964 |
Antiviral agents: the road from scepticism to efficacy.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Clinical Trials as Topic; Guanine; Hepatitis B; Herpesviridae Infections; Humans; Interferons; Ketones; Neoplasms; Phosphonoacetic Acid; Vidarabine; Virus Diseases | 1981 |
Herpes virus infections in patients with neoplastic disease. Diagnosis and therapy.
Topics: Acyclovir; Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Bromodeoxyuridine; Cloning, Molecular; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infectious Mononucleosis; Interferons; Kidney Transplantation; Leukemia; Lymphopenia; Neoplasms; Pulmonary Fibrosis; Vidarabine | 1984 |
Antiviral chemotherapy.
Topics: Acyclovir; Amantadine; Animals; Antiviral Agents; Bromodeoxyuridine; Female; Hepatitis B; Herpes Genitalis; Herpes Simplex; Herpes Zoster; Humans; Idoxuridine; In Vitro Techniques; Interferons; Male; Neoplasms; Papillomaviridae; Respiratory Tract Infections; Ribavirin; Rimantadine; Tumor Virus Infections; Vidarabine | 1984 |
[Importance of AgNOR analysis in malignant tumors].
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Cell Nucleus; DNA, Neoplasm; Flow Cytometry; Humans; Mitosis; Mitotic Index; Neoplasms; Nucleolus Organizer Region | 1994 |
Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.
Topics: Animals; Antimetabolites, Antineoplastic; Bromodeoxyuridine; Carcinogens; Histocytochemistry; Humans; Neoplasms | 1995 |
[Bromodeoxyuridine (BrdU). Analysis of cellular proliferation].
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Biopsy; Bromodeoxyuridine; Flow Cytometry; Humans; Immunohistochemistry; Neoplasms; Reference Values | 1997 |
The predictive role of flow cytometry-derived tumor potential doubling time (Tpot) in radiotherapy: open questions and future perspectives.
Topics: Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Forecasting; Guidelines as Topic; Humans; Models, Biological; Neoplasms; Predictive Value of Tests; Prognosis; Survival Analysis; Thymidine; Time Factors | 1998 |
Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; DNA; Flow Cytometry; Humans; Neoplasms; Ploidies | 2000 |
Targeting DNA mismatch repair for radiosensitization.
Topics: Antineoplastic Agents; Apoptosis; Base Pair Mismatch; Bromodeoxyuridine; Cell Cycle; Combined Modality Therapy; DNA Adducts; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Humans; Idoxuridine; Mutagenesis; Neoplasms; Nucleic Acid Synthesis Inhibitors; Radiation-Sensitizing Agents | 2001 |
[The "sarc" gene].
Topics: Alpharetrovirus; Animals; Base Sequence; Birds; Bromodeoxyuridine; Cell Transformation, Neoplastic; Dactinomycin; DNA-Directed RNA Polymerases; DNA, Viral; Genes; Idoxuridine; Mice; Neoplasms; Nucleic Acid Hybridization; RNA Viruses; RNA, Viral; X-Rays | 1975 |
Chemical modification of radiation effects.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Survival; Cysteamine; DNA; Drug Evaluation; Drug Interactions; Humans; Hypoxia; Metronidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation Effects; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1977 |
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Dactinomycin; DNA Repair; DNA, Neoplasm; Electrons; Fluorouracil; Humans; Hyperthermia, Induced; Hypoxia; Idoxuridine; Immunotherapy; Mice; Neoplasms; Neoplasms, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tourniquets; Ultrasonic Therapy | 1977 |
[Application of bromodeoxyuridine (BrdU) and anti-BrdU monoclonal antibody for the analysis of tumor cell kinetics by flow cytometry].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Neoplasms; Staining and Labeling; Tumor Cells, Cultured | 1992 |
[Flow cytometric BrdU/DNA assay for anticancer agent sensitivity test].
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Neoplasms; Staining and Labeling; Tumor Cells, Cultured | 1992 |
The future of flow cytometry.
Topics: Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Forecasting; Humans; Mitosis; Neoplasms; Nucleic Acid Denaturation | 1992 |
Measures of tumor proliferative activity.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Bromodeoxyuridine; Cell Division; Flow Cytometry; Humans; Neoplasms; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Thymidine | 1992 |
[The theory of flow cytometric analysis of the cell cycle and their applications in biology and oncology].
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cyclins; DNA; Flow Cytometry; Humans; Ki-67 Antigen; Neoplasm Proteins; Neoplasms; Nuclear Proteins | 1992 |
Clinical application of morphologic and immunocytochemical assessments of cell proliferation.
Topics: Bromodeoxyuridine; Cell Count; Cell Division; Histological Techniques; Humans; Immunohistochemistry; Mitosis; Neoplasms; Quality Control; Specimen Handling; Thymidine | 1992 |
The use of 5'-bromodeoxyuridine in the study of cell proliferation.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; DNA Replication; Flow Cytometry; Humans; Kinetics; Neoplasms | 1990 |
Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
Topics: Bromodeoxyuridine; Combined Modality Therapy; Humans; Idoxuridine; Neoplasms; Radiation-Sensitizing Agents | 1989 |
Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Combined Modality Therapy; Glutathione; Humans; Idoxuridine; Interleukin-1; Neoplasms; Nitroimidazoles; Oxidation-Reduction; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1989 |
Clinical applications of the bromodeoxyuridine/DNA assay.
Topics: Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Drug Resistance; Flow Cytometry; Humans; Neoplasms | 1988 |
Cell cycle analysis using flow cytometry.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Cell Line; Cytarabine; DNA; DNA, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Interphase; Kinetics; Mathematics; Mitosis; Models, Biological; Neoplasms; Sarcoma, Experimental | 1986 |
Considerations in the design of possible cell cycle effective drugs.
Topics: Alkylating Agents; Aneuploidy; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle; Cell Survival; DNA, Neoplasm; Flow Cytometry; Humans; Intercalating Agents; Interphase; Kinetics; Leukemia; Neoplasms; Thymidine | 1986 |
Cell kinetics and radiation biology.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Survival; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Radiation; Humans; Interphase; Kinetics; Mitosis; Neoplasms; Oxygen; Radiation Tolerance; Radiotherapy Dosage | 1986 |
The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy.
Topics: Animals; Bromodeoxyuridine; Buthionine Sulfoximine; Cell Survival; Cricetinae; Diamide; DNA Repair; Glutathione; Humans; Idoxuridine; In Vitro Techniques; Methionine Sulfoximine; Neoplasms; Radiation-Sensitizing Agents | 1986 |
Activation of mammalian leukemia viruses.
Topics: Animals; Antigens, Viral; Bromodeoxyuridine; Carcinogens; Cats; Cattle; Cell Transformation, Neoplastic; Cricetinae; Estrogens; Genes; Graft Rejection; Graft vs Host Reaction; Guinea Pigs; Haplorhini; Herpesviridae; Herpesvirus 4, Human; Humans; Idoxuridine; Leukemia Virus, Murine; Leukemia, Radiation-Induced; Lymphocyte Culture Test, Mixed; Lymphocytes; Mice; Neoplasms; Progestins; Prolactin; Radiation Effects; Rats; Retroviridae; RNA Viruses; RNA-Directed DNA Polymerase | 1974 |
Clinical use of radiation sensitizing agents.
Topics: Animals; Antimetabolites, Antineoplastic; Bleomycin; Bromodeoxycytidine; Bromodeoxyuridine; Bromouracil; Carcinoma, Squamous Cell; Dactinomycin; Dose-Response Relationship, Radiation; Floxuridine; Fluorouracil; Head and Neck Neoplasms; Humans; Hydroxyurea; Idoxuridine; Neoplasms; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1974 |
[Comparison of carcinogenesis and differentiation processes in normal cells].
Topics: Animals; Antigens; Bromodeoxyuridine; Carcinogens; Cell Differentiation; Cell Transformation, Neoplastic; Chromosomes; Dactinomycin; DNA; Genes; Genes, Regulator; Hybridization, Genetic; Mice; Mutagens; Mutation; Neoplasm Regression, Spontaneous; Neoplasms; RNA; Selection, Genetic | 1970 |
[Instability of phenotypes of tumor cells--on decarcinogenesis].
Topics: Amphibians; Animals; Anura; Bromodeoxyuridine; Carcinogens; Cell Differentiation; Cell Fusion; Cell Membrane; Dactinomycin; Daunorubicin; Hexokinase; Humans; Isoenzymes; Mice; Neoplasm Regression, Spontaneous; Neoplasm Transplantation; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Phenotype; Quinolines | 1971 |
2 trial(s) available for bromodeoxyuridine and Neoplasms
| Article | Year |
|---|---|
Antiviral agents: the road from scepticism to efficacy.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Clinical Trials as Topic; Guanine; Hepatitis B; Herpesviridae Infections; Humans; Interferons; Ketones; Neoplasms; Phosphonoacetic Acid; Vidarabine; Virus Diseases | 1981 |
The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers.
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Cell Survival; Clinical Trials as Topic; Combined Modality Therapy; Cricetinae; DNA Repair; Head and Neck Neoplasms; Humans; Idoxuridine; Mice; Neoplasms; Radiation-Sensitizing Agents | 1984 |
136 other study(ies) available for bromodeoxyuridine and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Influence of Hypoxia on Radiosensitization of Cancer Cells by 5-Bromo-2'-deoxyuridine.
Topics: Anaerobiosis; Bromodeoxyuridine; Cell Proliferation; Cell Survival; DNA Damage; Gene Expression Regulation, Neoplastic; Histones; Humans; MCF-7 Cells; Neoplasms; PC-3 Cells; Phosphorylation; Radiation-Sensitizing Agents; Tumor Hypoxia | 2022 |
Antitumor Activity of Tubulin-Binding Agent MPC-6827 on Different Types of Cancer Cell Lines.
Topics: Antineoplastic Agents; Apoptosis; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Female; HeLa Cells; Humans; Neoplasms; Quinazolines; Tubulin | 2022 |
Interleukin-11 (IL11) inhibits myogenic differentiation of C2C12 cells through activation of extracellular signal-regulated kinase (ERK).
Topics: Animals; Bromodeoxyuridine; Cachexia; Cell Differentiation; Extracellular Signal-Regulated MAP Kinases; Interleukin-11; Mice; Muscle Development; Myoblasts; Myogenin; Myosin Heavy Chains; Neoplasms | 2023 |
In focus in HCB.
Topics: Animals; Antineoplastic Agents; Brain; Bromodeoxyuridine; Cell Death; Cell Survival; Connectin; DNA Replication; Humans; Immunohistochemistry; Mice; Neoplasms; Nucleic Acid Denaturation; Telomere Homeostasis | 2017 |
Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant Cells.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Bystander Effect; Cell Line, Tumor; Deoxycytidine Kinase; Genes, Transgenic, Suicide; Genetic Therapy; HEK293 Cells; Humans; Male; Mice; Mice, SCID; Neoplasms; Prodrugs; Thymidine | 2019 |
Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Disease Models, Animal; Doublecortin Domain Proteins; Furin; Hippocampus; Humans; Immunohistochemistry; Mice, Transgenic; Microtubule-Associated Proteins; Neoplasms; Nerve Growth Factors; Neural Stem Cells; Neurogenesis; Neuropeptides | 2015 |
The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNA.
Topics: Animals; Antibodies; Bromodeoxyuridine; Cell Line, Tumor; Cytological Techniques; Disease Models, Animal; DNA; Heterografts; Humans; Immunohistochemistry; Mice; Neoplasms; Trifluridine | 2016 |
ProTides of BVdU as potential anticancer agents upon efficient intracellular delivery of their activated metabolites.
Topics: Amides; Animals; Antineoplastic Agents; Antiviral Agents; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Neoplasms; Phosphoric Acids | 2016 |
The effect of post-irradiation tumor oxygenation status on recovery from radiation-induced damage in vivo: with reference to that in quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Fluorescent Antibody Technique; Gamma Rays; Mice; Mice, Inbred C3H; Micronuclei, Chromosome-Defective; Neoplasms; Radiation Injuries; Radiation Tolerance | 2009 |
Delay of cell cycle progression and induction death of cancer cells on type I collagen fibrils [corrected].
Topics: Animals; Bromodeoxyuridine; Caspase 3; Caspase 9; Cattle; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Collagen Type I; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Focal Adhesions; Humans; Integrin alpha2beta1; Microscopy, Electron, Scanning; Neoplasms; Paxillin; Poly(ADP-ribose) Polymerases; Protein Transport; Proto-Oncogene Proteins c-akt; Time Factors | 2011 |
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cells.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Cycle Checkpoints; Cell Proliferation; Cyclin-Dependent Kinases; Dideoxynucleosides; Disease Models, Animal; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Piperazines; Positron-Emission Tomography; Pyridines; Thymidine; Xenograft Model Antitumor Assays | 2012 |
Organ differences in the impact of p27(kip1) deficiency on carcinogenesis induced by N-methyl-N-nitrosourea.
Topics: Adenocarcinoma; Alkylating Agents; Animals; Antimetabolites; Body Weight; Bromodeoxyuridine; Carcinogens; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p27; Genotype; Immunohistochemistry; Lymphoma; Male; Methylnitrosourea; Mice; Mice, Knockout; Neoplasms; Organ Size; Organ Specificity | 2013 |
Cell fate control gene therapy based on engineered variants of human deoxycytidine kinase.
Topics: Animals; Bromodeoxyuridine; Catalytic Domain; Cell Line, Tumor; Deoxycytidine Kinase; Deoxyuridine; Enzyme Activation; Genetic Engineering; Genetic Therapy; Genetic Vectors; Humans; Lentivirus; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms; Primary Cell Culture; Prodrugs; T-Lymphocytes; Thymidine; Transduction, Genetic; Xenograft Model Antitumor Assays | 2012 |
Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis.
Topics: Acrylic Resins; Adenosine Triphosphate; Biomechanical Phenomena; Bromodeoxyuridine; Cell Line, Tumor; Cellular Microenvironment; Cyclin D1; Extracellular Matrix; Humans; Isotope Labeling; Mass Spectrometry; Neoplasms; Protein Biosynthesis; Proteomics | 2012 |
Evidence that BRCA1- or BRCA2-associated cancers are not inevitable.
Topics: BRCA1 Protein; BRCA2 Protein; Bromodeoxyuridine; Cytoprotection; DNA Damage; Heterozygote; Humans; Lymphocytes; Micronuclei, Chromosome-Defective; Mutagens; Mutation; Neoplasms; Sister Chromatid Exchange | 2012 |
Design, synthesis, and in vitro and in vivo biological studies of a 3'-deoxythymidine conjugate that potentially kills cancer cells selectively.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Proliferation; Drug Design; Fluorescence; Humans; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mitochondria; Molecular Structure; Neoplasms; Quinoxalines; Superoxides; Thymidine; Tumor Cells, Cultured | 2012 |
Abnormal expression pattern of cyclin E in tumour cells.
Topics: Biomarkers, Tumor; Bromodeoxyuridine; Cell Cycle; Cell Line, Transformed; Cyclin A; Cyclin E; Down-Regulation; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Neoplasms; Survival Rate; Tumor Cells, Cultured | 2003 |
PPARgamma controls cell proliferation and apoptosis in an RB-dependent manner.
Topics: 3T3 Cells; Adipocytes; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Nucleus; Flow Cytometry; G1 Phase; G2 Phase; Gene Expression Regulation; Histone Deacetylases; In Situ Nick-End Labeling; Luciferases; Mice; Microscopy, Fluorescence; Mitosis; Neoplasms; Plasmids; Precipitin Tests; Receptors, Cytoplasmic and Nuclear; Retinoblastoma Protein; RNA, Small Interfering; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 2003 |
Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells.
Topics: Antioxidants; Bromodeoxyuridine; Catalase; Catechin; Epithelial Cells; Flavonoids; Humans; Neoplasms; Oxidative Stress; Phenols; Polymers; Reactive Oxygen Species; Superoxide Dismutase; Tea; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Effect of 5-bromodeoxyuridine on deoxyribonucleic acid-thymine synthesis and cell metabolism of lymphatic tissues and tumors.
Topics: Bromodeoxyuridine; DNA; DNA Replication; Lymphatic System; Lymphoid Tissue; Neoplasms; Nucleosides; Nucleotides; Thymine | 1958 |
The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man.
Topics: Antineoplastic Agents; Bromine; Bromodeoxycytidine; Bromodeoxyuridine; Deoxycytidine; Humans; Iodine Isotopes; Neoplasms; Radioisotopes; Radiometry; Radiotherapy | 1963 |
ORGANIZATION OF THE DEOXYRIBONUCLEIC ACID REPLICATING SYSTEM IN MAMMALIAN CELLS AS REVEALED BY THE USE OF X-RADIATION AND BROMURACIL DEOXYRIBOSIDE.
Topics: Bromine; Bromodeoxyuridine; Bromouracil; Carbon Isotopes; Cricetinae; DNA; DNA Replication; Neoplasms; Neoplasms, Experimental; Nucleosides; Radiation Effects; Research; Research Design; Thymidine; Tissue Culture Techniques; Tritium; X-Rays | 1964 |
STUDIES ON THE X-RAY SENSITIVITY OF HUMAN TUMOR CELLS EXPOSED TO 5-BROMODEOXYURIDINE.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Histocytochemistry; Neoplasms; Nucleosides; Pharmacology; Radiation Effects; Research; X-Rays | 1964 |
Quantitative studies of incorporation of exogenous thymidine and 5-bromodeoxyuridine into deoxyribonucleic acid of mammalian cells in vitro.
Topics: Bone Marrow; Bromodeoxyuridine; DNA; In Vitro Techniques; Neoplasms; Nucleosides; Nucleotides; Thymidine; Vegetables | 1961 |
The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat.
Topics: Animals; Bromodeoxycytidine; Bromodeoxyuridine; Mice; Neoplasms; Nucleosides; Nucleotides; Rats | 1962 |
14-3-3 sigma positively regulates p53 and suppresses tumor growth.
Topics: 14-3-3 Proteins; Active Transport, Cell Nucleus; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Blotting, Northern; Blotting, Western; Bromodeoxyuridine; Cell Line, Tumor; Cell Nucleus; DNA Damage; Down-Regulation; Doxycycline; Exonucleases; Exoribonucleases; Female; Genes, Reporter; Glutathione Transferase; Humans; Luciferases; Mice; Mice, Nude; Microscopy, Fluorescence; Models, Biological; Neoplasm Proteins; Neoplasms; NIH 3T3 Cells; Precipitin Tests; Protein Binding; Time Factors; Tumor Suppressor Protein p53; Ubiquitin | 2003 |
Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.
Topics: Acetylcysteine; Adherens Junctions; Animals; Blotting, Northern; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Claudin-1; Claudin-3; Claudin-4; Claudins; Cycloheximide; Detergents; Dogs; Epithelium; ErbB Receptors; Gene Expression Regulation; Hepatocyte Growth Factor; Immunoblotting; Kidney; Membrane Proteins; Microscopy, Fluorescence; Neoplasms; Octoxynol; Phenotype; Protein Synthesis Inhibitors; Signal Transduction; Tight Junctions; Time Factors | 2004 |
Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Separation; Coloring Agents; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Flow Cytometry; G1 Phase; Humans; Isothiocyanates; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Neoplasm Transplantation; Neoplasms; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; S Phase; Time Factors; Tumor Suppressor Proteins; Up-Regulation; Vegetables | 2004 |
An automated image capture and quantitation approach to identify proteins affecting tumor cell proliferation.
Topics: Automation; Bromodeoxyuridine; Carcinoma; Cell Division; Enzyme-Linked Immunosorbent Assay; Fluorescence; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Lung Neoplasms; Melanoma; Neoplasm Proteins; Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 2004 |
Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat.
Topics: Acrylamide; Animals; Apoptosis; Bromodeoxyuridine; Cell Division; DNA; Dose-Response Relationship, Drug; Drug Therapy, Combination; Environmental Pollutants; Male; Mitosis; Neoplasms; Organ Specificity; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Triazoles | 2004 |
Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression.
Topics: Alleles; Animals; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Proliferation; Cells, Cultured; Coloring Agents; Crosses, Genetic; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Genes, ras; Genotype; Heterozygote; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Mutation; MyoD Protein; Neoplasms; Pituitary Gland; Polymerase Chain Reaction; Protein Binding; Retinoblastoma Protein; Ribonucleases; Time Factors; Transcriptional Activation; Transgenes | 2004 |
Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate.
Topics: Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; G1 Phase; G2 Phase; Histone Deacetylase Inhibitors; Humans; Neoplasms; Oncogene Proteins, Viral; Protein Structure, Tertiary; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; Sodium Oxybate; Transfection; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2005 |
Very low intensity alternating current decreases cell proliferation.
Topics: Adenylate Kinase; Astrocytes; Blotting, Western; Bromodeoxyuridine; Caspase 3; Caspases; Cell Cycle; Cell Proliferation; Electric Stimulation; Epilepsy; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Hot Temperature; Humans; Immunohistochemistry; Neoplasms; Potassium; Potassium Channels, Inwardly Rectifying | 2005 |
Dependence of FDG uptake on tumor microenvironment.
Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals | 2005 |
Thymidine analogues to assess microperfusion in human tumors.
Topics: Animals; Benzimidazoles; Bromodeoxyuridine; Fluorescent Dyes; Humans; Idoxuridine; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Transplantation, Heterologous | 2005 |
The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclic N-Oxides; Female; Fluorescent Antibody Technique; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasm Transplantation; Neoplasms; Quinoxalines; Tirapazamine; Triazines | 2005 |
A novel platinum compound inhibits constitutive Stat3 signaling and induces cell cycle arrest and apoptosis of malignant cells.
Topics: Agar; Animals; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D1; Cytosol; DNA; Fibroblasts; Flow Cytometry; G1 Phase; Gene Expression Regulation; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Ki-67 Antigen; Kinetics; Luciferases; Mice; Neoplasms; NIH 3T3 Cells; Oligonucleotides; Oncogene Protein pp60(v-src); Piperazines; Plasmids; Platinum; Platinum Compounds; Protein Binding; Resting Phase, Cell Cycle; Signal Transduction; Time Factors | 2005 |
p53 codon 72 alleles influence the response to anticancer drugs in cells from aged people by regulating the cell cycle inhibitor p21WAF1.
Topics: Adult; Age Factors; Aged, 80 and over; Aging; Alleles; Antineoplastic Agents; Apoptosis; Arginine; beta-Galactosidase; Bromodeoxyuridine; Cell Cycle; Cell Death; Cell Separation; Cells, Cultured; Chromatin Immunoprecipitation; Codon; Cyclin-Dependent Kinase Inhibitor p21; Fibroblasts; Flow Cytometry; Homozygote; Humans; Luciferases; Microscopy, Fluorescence; Neoplasms; Oligonucleotides; Oxidative Stress; Polymorphism, Genetic; Proline; Propidium; Protein Isoforms; Transfection | 2005 |
Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine.
Topics: Adjuvants, Immunologic; Animals; Antibody Specificity; Antimetabolites; Bromodeoxyuridine; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Cytokines; Female; Immunoglobulin G; Interleukin-18; Kinetics; Mice; Mice, Inbred BALB C; Neoplasms; Plasmids; Stimulation, Chemical; T-Lymphocytes, Cytotoxic; Th1 Cells; Vaccines, DNA | 2006 |
Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dendritic Cells; DNA Primers; Forkhead Transcription Factors; Immunohistochemistry; Mice; Neoplasms; Rats; Rats, Inbred Strains; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; T-Lymphocytes, Regulatory; Transforming Growth Factor beta | 2005 |
Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Separation; Disease Models, Animal; Disease Progression; DNA-Binding Proteins; Flow Cytometry; Gene Deletion; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Ki-67 Antigen; Kinetics; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Neoplasms; Phosphoproteins; Prostatic Neoplasms; PTEN Phosphohydrolase; Stem Cells; Time Factors; Trans-Activators; Transcription Factors; Tumor Suppressor Proteins | 2006 |
Mechanisms of acrylamide induced rodent carcinogenesis.
Topics: Acrylamide; Animals; Bromodeoxyuridine; Carcinogens; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Comet Assay; Cricetinae; DNA; DNA Adducts; DNA Damage; Dose-Response Relationship, Drug; Fluorescent Dyes; Food Handling; Glutathione; Mesocricetus; Neoplasms; Rats; Rats, Inbred F344; Time Factors | 2005 |
Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.
Topics: Activating Transcription Factor 3; Animals; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Death; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Chromatin Immunoprecipitation; Cyclin D1; Dose-Response Relationship, Drug; Fibroblasts; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Transplantation; Neoplasms; Phosphorylation; Plasmids; ras Proteins; Retinoblastoma Protein; Retroviridae; S Phase; Time Factors; Transcription, Genetic; Ultraviolet Rays | 2006 |
Biocompatibility of cluster-assembled nanostructured TiO2 with primary and cancer cells.
Topics: Adsorption; Biocompatible Materials; Biosensing Techniques; Bromodeoxyuridine; Cell Adhesion; Cell Line, Tumor; Cluster Analysis; Cytoskeleton; DNA; Extracellular Matrix; Fibroblasts; Humans; Light; Materials Testing; Melanocytes; Microscopy, Atomic Force; Microscopy, Fluorescence; Nanostructures; Nanotechnology; Nanotubes; Neoplasms; Peptides; Scattering, Radiation; Surface Properties; Time Factors; Tissue Engineering; Titanium | 2006 |
DNA synthesis in tongue keratinocytes of hepatectomized and tumor-bearing mice.
Topics: Animals; Bromodeoxyuridine; Cell Nucleus; DNA; Hepatectomy; Keratinocytes; Male; Mice; Neoplasms; S Phase; Time Factors; Tongue | 2006 |
Impaired microRNA processing enhances cellular transformation and tumorigenesis.
Topics: Animals; Bromodeoxyuridine; Carcinogenicity Tests; Cell Line, Tumor; Cell Transformation, Neoplastic; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immunoblotting; Luciferases; Mice; MicroRNAs; Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Ribonuclease III | 2007 |
Flow cytometry after bromodeoxyuridine labeling to measure S and G2+M phase durations plus doubling times in vitro and in vivo.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Proliferation; Cells, Cultured; DNA; Flow Cytometry; Humans; Mice; Neoplasms; Rats; Staining and Labeling; Time Factors; Tissue Culture Techniques | 2006 |
Micronuclei bearing acentric extrachromosomal chromatin are transcriptionally competent and may perturb the cancer cell phenotype.
Topics: Bromodeoxyuridine; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatin; Humans; Lamin Type B; Micronuclei, Chromosome-Defective; Neoplasms; Nuclear Lamina; Phenotype; RNA; Transcription, Genetic | 2007 |
Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Everolimus; Female; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms; PTEN Phosphohydrolase; Ribonucleosides; Sirolimus; Trastuzumab | 2007 |
The effects inhibiting the proliferation of cancer cells by far-infrared radiation (FIR) are controlled by the basal expression level of heat shock protein (HSP) 70A.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; HSP70 Heat-Shock Proteins; Humans; Infrared Rays; Neoplasms; Oligonucleotide Array Sequence Analysis; RNA, Messenger; RNA, Small Interfering | 2008 |
Genome-wide promoter analysis uncovers portions of the cancer methylome.
Topics: Antimetabolites, Antineoplastic; Biotinylation; Bromodeoxyuridine; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Models, Genetic; Neoplasms; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic | 2008 |
Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
Topics: Bone Marrow; Bromodeoxyuridine; Drug Eruptions; Drug Evaluation; Glioblastoma; Humans; Infusions, Parenteral; Neoplasms; Radiation-Sensitizing Agents; Thrombocytopenia; Time Factors | 1984 |
A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
Topics: Adult; Brain Neoplasms; Bromodeoxyuridine; Female; Glioblastoma; Humans; Infusions, Parenteral; Male; Melanoma; Middle Aged; Neoplasms; Radiation-Sensitizing Agents; Sarcoma | 1984 |
Identification of bromodeoxyuridine in malignant and normal cells following therapy: relationship to complications.
Topics: Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Female; Humans; Melanoma; Neoplasms; Photosensitivity Disorders; Radiation-Sensitizing Agents; Skin | 1984 |
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Drug Evaluation; Female; Fever; Herpes Zoster; Humans; Male; Middle Aged; Neoplasms; Time Factors | 1984 |
Therapy of Herpes zoster infections.
Topics: Antiviral Agents; Bromodeoxyuridine; Herpes Zoster; Humans; Neoplasms | 1984 |
Elevated cytostatic activity of monocytes from cancer patients.
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Cytotoxicity, Immunologic; Female; Head and Neck Neoplasms; Humans; Inflammation; Mice; Monocytes; Neoplasms; Phytohemagglutinins; Thymidine; Tuberculosis, Pulmonary; Uterine Cervical Neoplasms | 1981 |
Analysis of sister-chromatid exchanges and tumorigenicity in cell hybrids.
Topics: Animals; Bromodeoxyuridine; Crossing Over, Genetic; Fibroblasts; Humans; Hybrid Cells; Lymphocytes; Melanoma; Mice; Neoplasms; Sister Chromatid Exchange | 1980 |
In situ analysis of cellular proliferation in canine, feline and equine tumors by immunohistochemistry: a comparison of bromodeoxyuridine, proliferating cell nuclear antigen, and interchromatin-associated antigen immunostaining techniques.
Topics: Animals; Antibodies, Monoclonal; Biomarkers, Tumor; Bromodeoxyuridine; Cat Diseases; Cats; Cell Division; Dog Diseases; Dogs; Horse Diseases; Horses; Immunohistochemistry; Neoplasms; Proliferating Cell Nuclear Antigen; Statistics as Topic | 1994 |
Combined immunocytochemistry and fluorescence in situ hybridization for simultaneous tricolor detection of cell cycle, genomic, and phenotypic parameters of tumor cells.
Topics: Alkaline Phosphatase; Bromodeoxyuridine; Cell Cycle; DNA Probes; DNA, Neoplasm; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Kinetics; Microscopy, Fluorescence; Neoplasm Proteins; Neoplasms; Neutral Red; Phenotype; Sensitivity and Specificity; Tumor Cells, Cultured | 1994 |
Tumor cell kinetics using two labels and flow cytometry.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Female; Flow Cytometry; Humans; Idoxuridine; In Vitro Techniques; Mice; Neoplasms; Tumor Cells, Cultured | 1994 |
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Topics: Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasms | 1994 |
In vitro bromodeoxyuridine labeling of malignant neoplasms. A comparative study with flow cytometry cell-cycle analysis.
Topics: Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Neoplasms | 1994 |
Cell proliferation and ploidy of human solid tumours: methodological experience with in vivo bromodeoxyuridine and DNA flow cytometry.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Feasibility Studies; Female; Flow Cytometry; Gastrointestinal Neoplasms; Glioma; Head and Neck Neoplasms; Humans; Neoplasms; Ovarian Neoplasms; Ploidies; Uterine Neoplasms | 1996 |
Detection of S-phase cells in smear cytology using in vitro bromodeoxyuridine labeling.
Topics: Animals; Bromodeoxyuridine; Coloring Agents; Humans; Male; Mice; Mice, Inbred C3H; Microtomy; Neoplasms; S Phase | 1996 |
In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
Topics: Aneuploidy; Antigens, Nuclear; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Linear Models; Male; Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Regression Analysis; Silver Staining; Transcription Factors | 1996 |
Steel's potential doubling time and its estimation in cell populations affected by nonuniform cell loss.
Topics: Bromodeoxyuridine; Cell Death; Cell Division; DNA, Neoplasm; Humans; Mathematics; Models, Biological; Neoplasms; Prognosis; Time Factors | 1997 |
Cell loss and the concept of potential doubling time.
Topics: Antimetabolites, Antineoplastic; Bromodeoxyuridine; Cell Division; Cell Survival; Flow Cytometry; Humans; Models, Biological; Neoplasms | 1997 |
Application of automatic thresholding in image analysis scoring of cells in human solid tumors labeled for proliferation markers.
Topics: Analysis of Variance; Bromodeoxyuridine; Color Perception; Humans; Image Processing, Computer-Assisted; Microtomy; Neoplasms; Paraffin Embedding; Proliferating Cell Nuclear Antigen; Reproducibility of Results; Sensory Thresholds; Staining and Labeling | 1997 |
[Determination of the potential doubling time of tumors using bromodeoxyuridine and flow cytometry].
Topics: Animals; Antimetabolites, Antineoplastic; Biopsy; Bromodeoxyuridine; Cat Diseases; Cats; Dog Diseases; Dogs; Flow Cytometry; Neoplasms; Prognosis; Time Factors | 1997 |
[Cell division: practical approach].
Topics: Bromodeoxyuridine; Cell Division; Humans; Idoxuridine; Immunohistochemistry; Ki-67 Antigen; Neoplasms; Proliferating Cell Nuclear Antigen | 1997 |
Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
Topics: Adenoviridae; Bromodeoxyuridine; Cell Cycle; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinases; Genetic Therapy; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Potential tumour doubling time: determination of Tpot for various canine and feline tumours.
Topics: Animals; Biopsy; Bromodeoxyuridine; Cat Diseases; Cats; Cell Cycle; DNA, Neoplasm; Dog Diseases; Dogs; Female; Flow Cytometry; Kinetics; Male; Mitotic Index; Neoplasms; Prognosis; Regression Analysis; Time Factors | 1998 |
Identification of nonproliferating but viable hypoxic tumor cells in vivo.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Hypoxia; Cell Separation; Flow Cytometry; Humans; Mice; Mice, SCID; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Proliferation indices as molecular pharmacodynamic endpoints in evaluation of anticancer drug effect in human solid tumors.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Division; DNA; Doxorubicin; Humans; Mitomycin; Neoplasms; Paclitaxel; Proliferating Cell Nuclear Antigen; Thymidine | 1998 |
Clinical radiosensitization: why it does and does not work.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Humans; Neoplasms; Radiation-Sensitizing Agents | 1999 |
Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts.
Topics: Animals; Bromodeoxyuridine; Cell Hypoxia; Humans; Mice; Mice, Nude; Neoplasms; Oxygen; Polarography; S Phase; Transplantation, Heterologous | 1999 |
Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Antioxidants; Biomarkers; Breast Neoplasms; Bromodeoxyuridine; Deoxyguanosine; DNA Damage; Female; Head and Neck Neoplasms; Humans; Hypoxanthine Phosphoribosyltransferase; Male; Micronucleus Tests; Middle Aged; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Smoking | 1999 |
Analysis of human tumors by laser scanning cytometry.
Topics: Apoptosis; Biomarkers, Tumor; Bromodeoxyuridine; Cell Nucleolus; Cyclins; DNA Fragmentation; DNA, Neoplasm; Female; Flow Cytometry; Fluorescent Dyes; HL-60 Cells; Humans; Image Cytometry; Immunohistochemistry; In Situ Hybridization, Fluorescence; In Situ Nick-End Labeling; Ki-67 Antigen; Neoplasms; NF-kappa B; Receptors, Estrogen | 2001 |
Laser cytometry of human tissues and tumors: proliferation and therapeutic applications.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Bromodeoxyuridine; Cell Division; Flow Cytometry; Humans; Idoxuridine; Image Cytometry; Neoplasm Invasiveness; Neoplasms; Prognosis; Time Factors; Treatment Outcome | 2001 |
Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells.
Topics: Amino Acid Sequence; Animals; Astrocytes; Astrocytoma; Brain; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; COS Cells; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Molecular Sequence Data; Molecular Weight; Neoplasms; Proteins; RNA-Binding Proteins | 2001 |
[76Br]Bromodeoxyuridine PET in tumor-bearing animals.
Topics: Animals; Bromine Radioisotopes; Bromodeoxyuridine; Cats; Dogs; Female; Flow Cytometry; Half-Life; Male; Mathematics; Neoplasms; Radiation-Sensitizing Agents; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Bax accelerates tumorigenesis in p53-deficient mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bromodeoxyuridine; Cell Division; Cell Survival; Disease-Free Survival; Female; Gene Expression Regulation; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neoplasms; Pregnancy; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Thymus Gland; Tumor Suppressor Protein p53 | 2001 |
Radiosensitization effect by combination with paclitaxel in vivo, including the effect on intratumor quiescent cells.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Survival; Humans; Mice; Mice, Inbred C3H; Micronucleus Tests; Neoplasms; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radiotherapy Dosage; Time Factors; Tirapazamine; Triazines | 2001 |
[Mathematical and simulating model of accelerated aging induced by 5-bromo-2-deoxyuridine].
Topics: Aging; Animals; Antimetabolites; Bromodeoxyuridine; Cell Death; Humans; Mathematics; Models, Biological; Neoplasms; Point Mutation; Stochastic Processes | 2001 |
Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Topics: Animals; Apoptosis; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cadmium; Carcinoma, Squamous Cell; Cytochalasin B; Fluorescent Antibody Technique; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Micronucleus Tests; Neoplasms; Neutrons; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Radiobiology; Radioisotopes; Relative Biological Effectiveness; Sarcoma, Experimental; Sulfhydryl Compounds; Tumor Cells, Cultured | 2001 |
E2F1 and E2F2 determine thresholds for antigen-induced T-cell proliferation and suppress tumorigenesis.
Topics: Age Factors; Animals; Antigens; Blotting, Western; Bromodeoxyuridine; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cells, Cultured; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; E2F2 Transcription Factor; Female; Flow Cytometry; Genotype; Lymph Nodes; Lymphocytes; Male; Mice; Mice, Knockout; Neoplasms; Ribonucleases; Spleen; T-Lymphocytes; Time Factors; Transcription Factors | 2001 |
Significance of the response of quiescent cell populations within solid tumors in cancer therapy.
Topics: Animals; Apoptosis; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Division; DNA Damage; Humans; Interphase; Mice; Micronucleus Tests; Neoplasms; Neoplasms, Experimental | 2002 |
Studies on effector cell-target cell interactions in vitro by means of the quantitative immunoadherence technique.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Bromodeoxyuridine; Cell Adhesion; Chickens; Cytotoxicity Tests, Immunologic; Epitopes; Immune Adherence Reaction; Immunity, Cellular; Lymphocytes; Mice; Neoplasm Transplantation; Neoplasms; Sarcoma, Avian; Spleen; Transplantation, Homologous | 1976 |
The effect of hyperthermia on DNA repair.
Topics: Acetoxyacetylaminofluorene; Bromodeoxyuridine; Cell Survival; DNA Repair; DNA, Neoplasm; Hot Temperature; Humans; Hyperthermia, Induced; Neoplasms | 1976 |
Effects of thymidine analogues on murine and human cells.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Line; Deoxyuridine; Fibroblasts; Floxuridine; Humans; Idoxuridine; Mice; Neoplasms; Neoplasms, Experimental; Thymidine | 1979 |
Sister chromatid exchanges in Bloom's syndrome.
Topics: Abnormalities, Multiple; Adult; Bromodeoxyuridine; Child; Child, Preschool; Chromatids; Erythema; Facial Dermatoses; Female; Genetic Techniques; Growth Disorders; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neoplasms; Photosensitivity Disorders; Pregnancy; Syndrome; Telangiectasis | 1978 |
Basic principles in radiation oncology.
Topics: Bromodeoxyuridine; Cell Division; DNA Repair; DNA, Neoplasm; Female; History, 20th Century; Humans; Hyperthermia, Induced; Immunotherapy; Male; Neoplasms; Oxygen; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Radiotherapy, High-Energy | 1977 |
Sister-chromatid exchanges and chromosal breakage in patients treated with cytostatics.
Topics: Bromodeoxyuridine; Busulfan; Chromatids; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Neoplasms | 1979 |
[Mechanism of and dosage in the combination of ionizing radiation and substances in tumor therapy].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Bromodeoxyuridine; Fluorouracil; Halogens; Humans; Neoplasms; Pyrimidine Nucleosides; Radiation-Sensitizing Agents; Radiography | 1978 |
Thymidine kinase, DNA synthesis and cancer.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Transformation, Neoplastic; Cytosol; DNA Replication; DNA, Neoplasm; Drug Resistance; Mitochondria; Neoplasms; Neoplasms, Experimental; Thymidine Kinase | 1976 |
In vivo labelling of human tumours with bromodeoxyuridine: a histopathologist's view.
Topics: Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Count; Flow Cytometry; Humans; Mitosis; Neoplasms | 1992 |
Simultaneous assessment of TGFB and cell cycle kinetics using IUdR/BrdU infusions in human neoplasms from plastic-embedded tissue.
Topics: Antibodies, Monoclonal; Biopsy; Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Female; Glioblastoma; Histological Techniques; Humans; Idoxuridine; Indicators and Reagents; Kinetics; Neoplasms; S Phase; Transforming Growth Factor beta | 1992 |
My favorite cytological subject: chromosomes.
Topics: Animals; Base Sequence; Bromodeoxyuridine; Cell Line; Chromosomes; Cricetinae; Cricetulus; Cytogenetics; History, 20th Century; Humans; In Situ Hybridization; Insecta; Mammals; Molecular Sequence Data; Neoplasms; Species Specificity; Telomere; Texas | 1992 |
Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; DNA Replication; DNA, Neoplasm; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia; Middle Aged; Neoplasms | 1991 |
Assessment of human tumour proliferation using bromodeoxyuridine--current status.
Topics: Aneuploidy; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Flow Cytometry; Humans; Neoplasms; Research | 1991 |
Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Colonic Neoplasms; DNA, Neoplasm; Flow Cytometry; Humans; Kinetics; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Ploidies; Rectal Neoplasms; Stomach Neoplasms; Transplantation, Heterologous | 1991 |
AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
Topics: Breast Neoplasms; Bromodeoxyuridine; Colonic Neoplasms; Goiter, Nodular; Humans; Interphase; Liver Neoplasms; Mitosis; Neoplasms; Nuclear Proteins; Nucleolus Organizer Region; Thyroid Neoplasms | 1991 |
Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Nucleus; DNA Replication; Gastrointestinal Neoplasms; Humans; Idoxuridine; Immunoenzyme Techniques; Leukemia; Leukemia, Myeloid; Neoplasms; S Phase | 1991 |
Cell proliferation in human tumour xenografts: measurement using antibody labelling against bromodeoxyuridine and Ki-67.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Nuclear Proteins; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | 1991 |
[Proliferative characteristics of the cells].
Topics: Antigens, Neoplasm; Autoradiography; Bromodeoxyuridine; Cell Cycle; DNA Polymerase II; DNA, Neoplasm; Flow Cytometry; Humans; Immunohistochemistry; Neoplasms; Thymidine | 1990 |
Patterns of BrdU incorporation in homogeneously staining regions and double minutes.
Topics: Animals; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; Chromosome Banding; Cricetinae; Cricetulus; DNA Replication; Genetic Markers; Humans; Karyotyping; Metaphase; Neoplasms; Staining and Labeling | 1986 |
In situ demonstration of tissue proliferative activity using anti-bromo-deoxyuridine monoclonal antibody.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; DNA; Epithelium; Humans; Immunohistochemistry; Interphase; Neoplasms; Nucleic Acid Denaturation; Pepsin A; Staining and Labeling | 1989 |
Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine.
Topics: Animals; Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Bromodeoxyuridine; Cell Nucleus; Histocompatibility Antigens Class II; Humans; Immunoenzyme Techniques; Immunohistochemistry; Interphase; Keratins; Lymphoid Tissue; Neoplasms; Rats; Tumor Cells, Cultured | 1989 |
In vivo bromodeoxyuridine labelling in human tumour xenografts.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Female; Humans; Male; Mice; Neoplasm Transplantation; Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1989 |
Can cell kinetic parameters predict the response of tumours to radiotherapy?
Topics: Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Humans; Neoplasms; Prognosis | 1989 |
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Breast Neoplasms; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Nucleus; Head and Neck Neoplasms; Humans; Immunohistochemistry; In Vitro Techniques; Interphase; Lymphoma; Neoplasms | 1989 |
[Flow cytometric analysis of cell proliferation kinetics using the anti-BrdUrd antibody].
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; Flow Cytometry; Humans; Interphase; Neoplasms | 1989 |
[Cell kinetic study of human carcinomas using bromodeoxyuridine and immunohistochemistry].
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Cycle; DNA Replication; Female; Gastrointestinal Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Prognosis | 1989 |
[Tumor doubling time studied with in vivo administration of bromodeoxyuridine and flow cytometry: preliminary report].
Topics: Bromodeoxyuridine; Flow Cytometry; Humans; Neoplasms; Time Factors | 1989 |
[5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Neoplasms; Opportunistic Infections | 1988 |
Immunocytochemical labeling of S-phase cells of human tumors by monoclonal antibodies in vitro.
Topics: Antibodies, Monoclonal; Autoradiography; Bromodeoxyuridine; DNA, Neoplasm; Female; Humans; Immunohistochemistry; Interphase; Neoplasms; Tumor Cells, Cultured | 1988 |
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
Topics: Autoradiography; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; Neoplasms | 1988 |
Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
Topics: Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Flow Cytometry; Humans; Mitosis; Neoplasms; Time Factors | 1988 |
Estimating tumor doubling time via flow cytometry.
Topics: Bromodeoxyuridine; Cell Division; Cell Separation; Flow Cytometry; Humans; Neoplasms | 1988 |
Relationship between labeling indices of Ki-67 and BrdUrd in human malignant tumors.
Topics: Adenocarcinoma; Antigens; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Humans; Neoplasms; Nuclear Proteins | 1988 |
B-cell colony growth of malignant and normal B-cells.
Topics: B-Lymphocytes; Bromodeoxyuridine; Colony-Forming Units Assay; DNA; Humans; Interleukin-2; Leukemia, Hairy Cell; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Neoplasms; Phytohemagglutinins; Tetradecanoylphorbol Acetate | 1987 |
Immunological determination of labeling index on human tumor tissue sections using monoclonal anti-BrdUrd antibody.
Topics: Adult; Aged; Antibodies, Monoclonal; Bromodeoxyuridine; Female; Fluorescent Antibody Technique; Humans; Kinetics; Male; Middle Aged; Mitosis; Mitotic Index; Neoplasms | 1986 |
In vitro immunohistochemical localization of S-phase cells by a monoclonal antibody to bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Bromodeoxyuridine; DNA; Histocytochemistry; Humans; Immunoenzyme Techniques; Interphase; Neoplasms; Nucleic Acid Denaturation | 1986 |
Flow cytometry as a tool for the prognostic assessment of human neoplasia.
Topics: Aneuploidy; Bromodeoxyuridine; Diploidy; DNA, Neoplasm; Flow Cytometry; Humans; Interphase; Neoplasms; Precancerous Conditions | 1986 |
Rapid fluorometric detection of drug resistant tumour cells.
Topics: Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Line; Dose-Response Relationship, Drug; Drug Resistance; Fluorescent Antibody Technique; Mice; Mutation; Neoplasms; Thioguanine | 1985 |
[Radiation sensitizers: with special reference to hypoxic cell sensitizers].
Topics: Animals; Bromodeoxyuridine; Cells, Cultured; Humans; Misonidazole; Neoplasms; Oxygen; Partial Pressure; Radiation-Sensitizing Agents | 1986 |
Oral BVDU treatment of varicella and zoster in children with cancer.
Topics: Administration, Oral; Adolescent; Animals; Antiviral Agents; Bromodeoxyuridine; Chickenpox; Child; Child, Preschool; Female; Herpes Zoster; Humans; Male; Neoplasms | 1985 |
The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Cell Cycle; DNA, Neoplasm; Flow Cytometry; Humans; In Vitro Techniques; Interphase; Mice; Neoplasms; Ploidies; Sarcoma, Experimental; Tritium | 1985 |
[The use of radiosensitizing agents in radiotherapy].
Topics: Brain Neoplasms; Bromodeoxyuridine; Dactinomycin; DNA; Fluorouracil; Glycogen; Humans; Neoplasms; Oxygen; Radiation-Sensitizing Agents; RNA; Vitamin K | 1972 |
Induction of C-type particles in mammalian cancer cells.
Topics: Animals; Arginine; Avian Sarcoma Viruses; Birds; Bromodeoxyuridine; Carcinoma; Cell Transformation, Neoplastic; Cells, Cultured; Culture Media; Genotype; Humans; Leukemia; Leukocytes; Neoplasms; Neoplasms, Experimental; Retroviridae; RNA-Directed DNA Polymerase; RNA, Viral; Sarcoma, Avian; Virus Cultivation; Virus Replication | 1974 |
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Bromodeoxyuridine; Cell Line; Clone Cells; Connective Tissue; Female; Gammaretrovirus; Goats; Leukemia; Liver; Melanoma; Mice; Mice, Inbred Strains; Neoplasms; Neoplasms, Experimental; Neuroblastoma; Radioimmunoassay; Rauscher Virus; Retroviridae; RNA-Directed DNA Polymerase; Sarcoma 180; Spleen; Tritium; Virus Cultivation | 1974 |
Virogenic properties of bromodeoxyuridine-sensitive and bromodeoxyuridine-resistant simian virus 40-transformed mouse kidney cells.
Topics: Animals; Antigens; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; Culture Techniques; Cytopathogenic Effect, Viral; Haplorhini; Immune Sera; Kidney; Mice; Neoplasms; Simian virus 40; Tritium | 1967 |
[Trial and results of improved radiotherapy for cancer. 5. Radiotherapy with simultaneous administration of radio-sensitizing agents. Administration of halogenated pyrimidine].
Topics: Bromodeoxyuridine; Fluorouracil; Humans; Neoplasms; Radiation-Sensitizing Agents; Tongue Neoplasms | 1972 |
Theoretical evaluation of a limitation in the use of pyrimidine analogs in radiation therapy.
Topics: Bromodeoxyuridine; Culture Techniques; Deoxyuridine; Idoxuridine; Neoplasms; Neoplasms, Experimental; Pyrimidines; Radiation-Sensitizing Agents | 1966 |